The Role of Menopausal Hormone thrapy in Reducing All-cause Mortality in Postmenopausal Women Younger than 60 Years: An Adaptive Meta-analysis

참고문헌 (18)

1. Santen RJ, "Postmenopausal hormone therapy:an Endocrine Society scientific statement", J Clin Endocrinol Metab, 95, pp.s1~s66 (2010)
2. Boardman HM, "Hormone therapy for preventing cardiovascular disease in post-menopausal women", Cochrane Database Syst Rev, 3, pp.002229~ (2015)
3. Schierbeck LL, "Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women:randomised trial", BMJ, 345, pp.e6409~ (2012)
4. "Maturitas", 2006, 162~173
5. Nachtigall LE, "Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems", Obstet Gynecol, 54, pp.74~79 (1979)
6. Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women’s Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
7. Anderson GL, "Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial", JAMA, 291, pp.1701~1712 (2004)
8. Gartlehner G, "Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: An evidence review for the U.S. preventive services task force", pp.15-05227-E~ (2017), Agency for Healthcare Research and Quality
9. LaCroix AZ, "Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial", JAMA, 305, pp.1305~1314 (2011)
10. Grossman DC, "Hormone therapy for the primary prevention of chronic conditions in postmenopausal women:US preventive services task force recommendation statement", JAMA, 318, pp.2224~2233 (2017)
11. 배종면, "Citation Discovery Tools for Conducting Adaptive Meta-analyses to Update Systematic Reviews", 예방의학회지, 49(2), pp.129~133 (2016), 대한예방의학회
12. Manson JE, "Menopausal hormone therapy and long-term all-cause and cause-specific mortality: The women’s health initiative randomized trials", JAMA, 318, pp.927~938 (2017)
13. Cherry N, "Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial", BJOG, 121, pp.700~705 (2014)
14. Hulley S, "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women", JAMA, 280, pp.605~613 (1998)
15. Hulley S, "Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen", progestin Replacement Study follow-up (HERS II), 2002, pp.288, 58~66
16. Bibbins-Domingo K, "Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease", Am J Cardiol, 95, pp.289~291 (2005)
17. Bae JM, "Citrus fruit intake and stomach cancer risk: a quantitative systematic review", Gastric Cancer, 11, pp.23~32 (2008)
18. 심성률, "중재 메타분석을 위한 STATA 명령어", 보건정보통계학회지, 41(1), pp.123~134 (2016), 한국보건정보통계학회[DOI]

관련 논문AI추천